Tuberculosis and HIV Infection in IV Drug Users

Graham, Neil M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute on Drug Abuse (NIDA)
• Type: Research Project (R01)
• Project #: 3R01DA007061-03S2
• Application #: 2119346
• Study Section: Special Emphasis Panel (SRCD (49))
• Project Start: 1992-05-15
• Project End: 1997-04-30
• Budget Start: 1994-09-01
• Budget End: 1995-04-30
• Support Year: 3
• Fiscal Year: 1994

Institution

• Name: Johns Hopkins University
• Department: Public Health & Prev Medicine
• Type: Schools of Public Health
• DUNS #: 045911138
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21218

Publications

Sadaphal, P; Astemborski, J; Graham, N M et al. (2001) Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis 33:1687-91

Sterling, T R; Moore, R D; Graham, N M et al. (1998) Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. AIDS 12:1451-7

Goletti, D; Weissman, D; Jackson, R W et al. (1996) Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 157:1271-8

Caiaffa, W T; Vlahov, D; Graham, N M et al. (1994) Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med 150:1493-8

Graham, N M; Chaisson, R E (1993) Tuberculosis and HIV infection: epidemiology, pathogenesis, and clinical aspects. Ann Allergy 71:421-8;quiz 428-33

Caiaffa, W T; Graham, N M; Vlahov, D (1993) Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 138:909-22